ArticleJournal of Cancer2019

Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study.

Antonino Grassadonia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.